* Medifast Inc is expected to show a fall in quarterly revenue when it reports results on November 4 for the period ending September 30 2024

* The Owings Mills Maryland-based company is expected to report a 43.1% decrease in revenue to $134.15 million from $235.87 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on August 5 2024, for the period ended September 30, was for revenue between $125.00 million and $145.00 million.

* ​LSEG's mean analyst estimate for Medifast Inc is for a loss of 28 cents per share. The company's EPS guidance on August 5 2024, for the period ended September 30, was between $-0.70 and $-0.05

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for Medifast Inc is 17.25​, below​ its last closing price of $18.58. ​​​

This summary was machine generated November 2 at 03:50 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)